Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-04-09 09:42 am Purchase | 13G | HALOZYME THERAPEUTICS INC HTI | Artisan Partners Limited Partnership | 14,430,037 10.5% | 14,430,037 (New Position) | View |
| 2020-02-14 2:39 pm Sale | 13G | HALOZYME THERAPEUTICS INC HTI | BB BIOTECH AG | 7,963,056 5.4% | -359,804 (-4.32%) | View |
| 2020-02-10 2:24 pm Purchase | 13G | HALOZYME THERAPEUTICS INC HTI | VANGUARD GROUP INC | 14,023,459 10.25% | 20,304 (+0.14%) | View |
| 2020-02-10 1:41 pm Purchase | 13G | HALOZYME THERAPEUTICS INC HTI | VANGUARD GROUP INC | 14,003,155 9.55% | 531,237 (+3.94%) | View |
| 2020-02-10 07:32 am Purchase | 13G | HALOZYME THERAPEUTICS INC HTI | BlackRock Inc. BLK | 12,096,797 8.3% | 340,677 (+2.90%) | View |
| 2020-01-28 09:56 am Sale | 13G | HALOZYME THERAPEUTICS INC HTI | IRIDIAN ASSET MANAGEMENT LLC | 0 0% | -11,157,939 (Position Closed) | View |
| 2019-11-05 4:53 pm Sale | 13D | HALOZYME THERAPEUTICS INC HTI | KIRK RANDAL J | 7,046,385 4.8% | -3,497,856 (-33.17%) | View |
| 2019-07-03 4:01 pm Sale | 13D | HALOZYME THERAPEUTICS INC HTI | KIRK RANDAL J | 10,544,241 7.2% | -1,567,633 (-12.94%) | View |
| 2019-06-07 5:10 pm Sale | 13D | HALOZYME THERAPEUTICS INC HTI | KIRK RANDAL J | 12,111,874 8.3% | -1,980,897 (-14.06%) | View |